Long-range cholinergic input promotes glioblastoma progression
Cancer Cell · 2025-11 · 43 (11) · 2089-2105.e10
DOI: 10.1016/j.ccell.2025.07.024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2025-11. Verfasst von Yang Yang und 34 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology & Southwest Cancer Center, Glioma Medical Research Center, Southwest Hospital, Third Military Medical University (Army Medical…. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Acetylcholine. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 93 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chongqing Municipal Science and Technology Bureau, Postdoctoral Research Foundation of China.
Abstract (Originalsprache)
Glioblastoma (GBM), the most aggressive primary brain tumor, is shaped by its integration into neural networks. While glutamatergic input is linked to tumor progression, the broader architecture and function of neuron-glioma connectomes remain unclear. Using monosynaptic rabies tracing, we map brain-wide neural input to patient-derived xenografts and reveal a consistent organizational logic: local inputs are primarily glutamatergic, while long-range connections exhibit diverse neurotransmitter profiles, with basal forebrain cholinergic projections emerging as a conserved input across sites. Functionally, presynaptic acetylcholine release promotes GBM progression through muscarinic receptor CHRM3 in a circuit-specific manner. Mechanistically, glutamatergic and cholinergic signals converge to enhance glioma calcium transients but diverge in temporal transcriptional control, with their dual blockade producing additive anti-tumor effects. Therapeutically, the anticholinergic drug scopolamine attenuates glioma growth, whereas the acetylcholinesterase inhibitor donepezil exacerbates disease. These findings reveal the complexity of neuron-glioma connectivity, highlighting long-range neuromodulatory pathways as promising therapeutic targets in GBM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pathology & Southwest Cancer Center, Glioma Medical Research Center, Southwest Hospital, Third Military Medical University (Army Medical University), and The Key Laboratory of Tumor Immunopathology, The Min…
- Department of Neurosurgery, Glioma Medical Research Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China.
- Department of Pathology, Public Health Medical Center, Chongqing 400036, China.
- Department of Neurosurgery, No.904 Hospital, Anhui Medical University, Wuxi 214044, China.
- Department of Neurosurgery, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
- Department of Ultrasound, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China.
Förderung
- National Natural Science Foundation of China
- Chongqing Municipal Science and Technology Bureau
- Postdoctoral Research Foundation of China
- Peking University
- Southwest Hospital
Zitieren
APA
Yang, Y., Yang, C., Chen, X., Jiang, Y., Lei, X., Ma, K., Quan, Y., Li, T., Guo, C., Meng, Y., Kang, L., Zhang, X., Jin, L., Huang, J., Mu, N., Yan, Z., Ma, Q., Wang, S., Wang, Y., …, & Chen, T. (2025). Long-range cholinergic input promotes glioblastoma progression. Cancer Cell, 43(11), 2089-2105.e10. https://doi.org/10.1016/j.ccell.2025.07.024
Vancouver
Yang Y, Yang C, Chen X, Jiang Y, Lei X, Ma K, et al. Long-range cholinergic input promotes glioblastoma progression. Cancer Cell. 2025;43(11):2089-2105.e10. doi:10.1016/j.ccell.2025.07.024
BibTeX
@article{Yang2025,
author = {Yang, Yang and Yang, Chuanyan and Chen, Xuezhu and Jiang, Yibin and Lei, Xuejiao and Ma, Kang and Quan, Yulian and Li, Tianran and Guo, Chenfu and Meng, Yijing and Kang, Lin and Zhang, Xinyu and Jin, Long and Huang, Jiafeng and Mu, Ning and Yan, Zexuan and Ma, Qinghua and Wang, Shuai and Wang, Yanxia and Shang, Yong-Ning and Chen, Cong and Shi, Yu and Hu, Shukun and Yang, Likun and Lan, Chuan and Hu, Rong and Zhang, Ying and Li, Xia and Li, Yunqing and Liu, Chong and Wang, Yu-Hai and Li, Fei and Feng, Hua and Bian, Xiu-Wu and Chen, Tunan},
title = {Long-range cholinergic input promotes glioblastoma progression},
journal = {Cancer Cell},
year = {2025},
volume = {43},
number = {11},
pages = {2089--2105.e10},
doi = {10.1016/j.ccell.2025.07.024}
}
EUVIMED